Evaluation of community pharmacist follow-up supported by the use of healthcare technology for type 2 diabetes patients.

Lallemand, A; Verrue, C; Santi, A; Delhaye, N; Willaert, M; Attipoe, A; Tomas, M; Philippe, G

Lallemand, A; Verrue, C; Santi, A; Delhaye, N; Willaert, M; Attipoe, A; Tomas, M; Philippe, G.

Afiliación

Lallemand A; Center for Interdisciplinary Research on Medicines, Faculty of Medicine, University of Liege, Liege, Belgium.
Verrue C; Multipharma SC, Brussels, Belgium.
Santi A; Multipharma SC, Brussels, Belgium.
Delhaye N; Multipharma SC, Brussels, Belgium.
Willaert M; Comunicare Solutions SA, Liege, Belgium.
Attipoe A; Comunicare Solutions SA, Liege, Belgium.
Tomas M; Comunicare Solutions SA, Liege, Belgium.
Philippe G; Center for Interdisciplinary Research on Medicines, Faculty of Medicine, University of Liege, Liege, Belgium.

Explor Res Clin Soc Pharm ; 12: 100330, 2023 Dec.

Article en En | MEDLINE | ID: mdl-37743852

Palabras clave

Community pharmacist; Medication adherence; Mobile health application; Therapeutic patient education; Type 2 diabetes

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Tipo de estudio: Evaluation_studies / Qualitative_research / Risk_factors_studies Idioma: En Revista: Explor Res Clin Soc Pharm Año: 2023 Tipo del documento: Article País de afiliación: Bélgica

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google